DAINO, Lucia Maria Elisa
 Distribuzione geografica
Continente #
NA - Nord America 1.038
EU - Europa 666
AS - Asia 343
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 1
Totale 2.054
Nazione #
US - Stati Uniti d'America 1.032
CN - Cina 268
UA - Ucraina 266
SE - Svezia 100
DE - Germania 93
IT - Italia 56
FR - Francia 44
FI - Finlandia 43
CZ - Repubblica Ceca 28
TR - Turchia 28
GB - Regno Unito 25
SG - Singapore 25
IR - Iran 8
BE - Belgio 6
CA - Canada 5
IN - India 5
KR - Corea 4
AU - Australia 3
EU - Europa 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
IL - Israele 1
PA - Panama 1
RO - Romania 1
Totale 2.054
Città #
Chandler 290
Jacksonville 161
Princeton 82
Dearborn 70
Nanjing 58
Wilmington 43
Ann Arbor 39
Sassari 38
Nanchang 36
Boardman 27
Woodbridge 27
Brno 26
Beijing 25
Izmir 24
Shenyang 21
Changsha 17
Tianjin 16
Singapore 14
Hebei 12
Zhengzhou 12
Jiaxing 11
Ningbo 11
Norwalk 10
Augusta 9
Hangzhou 9
Jinan 9
Dallas 8
Leawood 8
Ardabil 7
Guangzhou 7
San Mateo 7
Brussels 6
Munich 6
Taizhou 6
Falls Church 5
Kunming 5
Monmouth Junction 5
Mountain View 5
Auburn Hills 4
Los Angeles 4
New York 4
San Francisco 4
Seoul 4
Toronto 4
Andover 3
Ashburn 3
Cagliari 3
Changchun 3
Grézieu-la-varenne 3
Helsinki 3
Torino 3
Berlin 2
Canberra 2
Hefei 2
Olomouc 2
Rome 2
Tappahannock 2
Alghero 1
Bridlington 1
Brierley Hill 1
Cedar Knolls 1
Chalfont 1
Chicago 1
Chittagong 1
Dhaka 1
Dubai 1
Edinburgh 1
Edmonton 1
Haifa 1
Huntington 1
Lanzhou 1
Panama City 1
Pune 1
Raleigh 1
Shanghai 1
Sofia 1
Stockholm 1
São Paulo 1
Tallinn 1
Xian 1
Zurich 1
Totale 1.253
Nome #
Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain 81
Role of HSP90,CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer 76
Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells 71
Post-translational deregulation of YAP1 is genetically controlled in rat liver cancer and determines the fate and stem-like behavior of the human disease 63
ROLE OF YAP SIGNALLING DEREGULATION IN THE GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS, AND STEMNESS AND AGGRESSIVITY OF LIVER CANCER 59
Dependence of benzo(a)pyrene metabolism on NADPH pool in normal and glucose-6-phosphate dehydrogenase deficient human fibroblasts. 59
Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis 58
Modulatory effect of glucose-6-phosphate dehydrogenase deficiency on benzo(a)pyrene toxicity and transforming activity for in vitro-cultured human skin fibroblasts. 57
Effect of S-adenosyl-L-methionine on the development of preneoplastic foci and the activity of some carbohydrate metabolizing enzymes in the liver, during experimental hepatocarcinogenesis. 57
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. 55
c-myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model 55
Dual-Specific Phosphatase 1 Ubiquitination in Extracellular Signal-Regulated Kinase-Mediated control of Grawth in Human Hepatocellular Carcinoma 55
Phenotypic reversion of rat neoplastic liver nodules is under genetic control 53
Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: is DNA methylation involved? 53
Reversal by ribo- and deoxyribonucleosides of dehydroepiandrosterone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation--selection process of experimental carcinogenesis. 53
Benzo(a)pyrene metabolism by lymphocytes from normal individuals and individuals carrying the Mediterranean variant of glucose-6-phosphate dehydrogenase. 53
Inhibition by dehydroepiandrosterone of growth and progression of persistent liver nodules in experimental rat liver carcinogenesis 52
Differential effects of dehydroepiandrosterone and deoxyribonucleosides on DNA synthesis and de novo cholesterogenesis in hepatocarcinogenesis in rats. 52
. Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. 52
Long-term dehydroepiandrosterone and 16alfa-fluoro-5-androsten-17-one administration enhances DNA synthesis and induces expression of c-fos and c-Ha-ras in a selected population of preneoplastic lesions in liver of diethylnitrosamine-initiated rats 52
Protooncogene methylation and expression in regenerating liver and preneoplastic liver nodules induced in the rat by diethylnitrosamine: effect of variations of S-adenosylmethionine:S-adenosylhomocysteine ratio. 51
Variations of ornithine decarboxylase activity and S-adenosyl-L-methionine and 5'-methylthioadenosine contents during the development of diethylnitrosamine-induced liver hyperplastic nodules and hepatocellular carcinoma. 51
Epigenetics of liver cancer progression: Role of transcriptional and post-transcriptional regulation of methionine adenosyltransferases in liver cancer progression. 50
Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease 50
Alterations of ornithine decarboxylase gene during the progression of rat liver carcinogenesis. 50
Mapping a sex-hormone sensitive gene determining female resistance to liver carcinogenesis in a congenic F344 BN-Hcs4 rat. 49
Transferrin and transferrin receptor gene expression and iron upteke in hepatocellular carcinoma in the rat 48
Correlation between S-adenosyl-L-methionine content and production of c-myc, c-Ha-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. 48
Role of transcriptional and postttranscriptional regulation of methionine adenosyltransferases in liver cancer progression. 48
Comparative effects of L-methionine, S-adenosyl-L-methionine and 5'-methylthioadenosine on the growth of preneoplastic lesions and DNA methylation in rat liver during the early stages of hepatocarcinogenesis 47
An expression signature of phenotipic resistance to hepatocellular carcinoma identified by cross-species gene expression analysis 47
Ruolo di HSP90, CDC37 e CRM1 come modulatori dell’attività di p16 INK4A nella cancerogenesi epatica di ratto e nel carcinoma epatocellulare umano 46
Reversal by 5-azacytidine of the S-adenosyl-L-methionine-induced inhibition of the development of putative preneoplastic foci in rat liver carcinogenesis 45
Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control 44
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype 43
Mapping a sex hormone-sensitive gene determining female resistance to liver carcinogenesis in a congenic F344.BN-Hcs4 rat 41
Modulation of P16INK4 activity by HSP90, Cdc37 and CRM1 influences the progression of preneoplastico lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 36
Modulation of P16INK4A activity by Hsp90, Cdc37 and CRM1 influences the progression of preneoplastic lesions in rats with different predisposition to liver cancer and the prognosis of human hepatocellular carcinoma 36
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53 35
Reversal by 5-azacytidine of the s-adenosyl-L-methionine induced inhibition of the development of putative preneoplastic foci in rat-liver 34
Nuclear localization dictates hepatocarcinogenesis suppression by glycine N-methyltransferase 26
Totale 2.091
Categoria #
all - tutte 9.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.996


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020378 0 11 38 2 40 58 105 9 48 19 46 2
2020/2021389 43 1 58 3 40 18 44 1 54 57 58 12
2021/2022220 42 1 0 3 8 3 13 11 17 21 21 80
2022/2023505 54 48 10 91 42 88 0 56 87 1 14 14
2023/2024126 34 9 1 2 13 3 0 3 0 0 13 48
2024/202521 7 14 0 0 0 0 0 0 0 0 0 0
Totale 2.091